Evidence map›Paper›PMID 34343089›Full record

ArticleeLife2021

Instability in NAD

Knut H Lauritzen, Maria Belland Olsen, Mohammed Shakil Ahmed, Kuan Yang, Johanne Egge Rinholm, Linda H Bergersen, Qin Ying Esbensen, Lars Jansen Sverkeli, Mathias Ziegler, Håvard Attramadal and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Trial
  2. Tracing NADCell reports · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. NADCommunications biology · 2026
    Article
  7. Tracing NADResearch square · 2025
    Article
  8. The Role of NADAmerican journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Review
  9. Mitochondrial dysfunction is a major cause of thromboinflammation and inflammatory cell death in critical illnesses.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  10. Article
  11. Review
  12. NAD metabolism and heart failure: Mechanisms and therapeutic potentials.Journal of molecular and cellular cardiology · 2024
    Review
  13. NAD in pathological cardiac remodeling: Metabolic regulation and beyond.Biochimica et biophysica acta. Molecular basis of disease · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Sexually dimorphic effects of SARM1 deletion on cardiac NADAmerican journal of physiology. Heart and circulatory physiology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Knut H LauritzenResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.ORCID 0000-0002-6003-6027
Maria Belland OlsenResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.
Mohammed Shakil AhmedInstitute for Surgical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Kuan YangResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.ORCID 0000-0002-2246-4864
Johanne Egge RinholmDepartment of Microbiology, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-3741-850X
Linda H BergersenDepartment of Oral Biology, University of Oslo, Oslo, Norway.
Qin Ying EsbensenDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Nordbyhagen, Norway.
Lars Jansen SverkeliDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Mathias ZieglerDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID 0000-0001-6961-2396
Håvard AttramadalInstitute for Surgical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
Bente HalvorsenResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.ORCID 0000-0002-6529-6485
Pål AukrustResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.
Arne YndestadResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Bergen · NOUniversity of Copenhagen · DKUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(ADP-ribose) polymerase (PARP) enzymes initiate (mt)DNA repair mechanisms and use nicotinamide adenine dinucleotide (NAD

Indexed as

DNA RepairAnimalsDNA DamageDNA, MitochondrialHeartHeart DiseasesHeLa CellsHumansMiceMitochondriaMyocardiumNADNiacinamidePyridinium CompoundsSirtuinsDNA, MitochondrialNADNiacinamidenicotinamide-beta-ribosidePyridinium CompoundsSirtuinsbiochemistrycardiovascular diseasechemical biologyDNA repairhumanmitochondrial dnamouseNAD+nicotinamide ribosideSIRT3

Identifiers

PMID34343089
PMCPMC8331182
OpenAlexW3192132438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.